0001209191-18-041915.txt : 20180706
0001209191-18-041915.hdr.sgml : 20180706
20180706200244
ACCESSION NUMBER: 0001209191-18-041915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180705
FILED AS OF DATE: 20180706
DATE AS OF CHANGE: 20180706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neff Thomas B
CENTRAL INDEX KEY: 0001623238
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 18943205
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS ST.
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-05
0
0000921299
FIBROGEN INC
FGEN
0001623238
Neff Thomas B
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO
CA
94158
1
1
0
0
Chief Executive Officer
Common Stock
2018-07-05
4
M
0
10320
3.60
A
2839193
D
Common Stock
2018-07-05
4
S
0
13500
63.97
D
2825693
D
Common Stock
2018-07-05
4
S
0
5400
64.62
D
2820293
D
Common Stock
2018-07-05
4
S
0
818
63.92
D
106828
I
By Family Partnership
Common Stock
2018-07-05
4
S
0
100
64.75
D
106728
I
By Family Partnership
Common Stock
2018-07-06
4
M
0
10320
3.60
A
2830613
D
Common Stock
2018-07-06
4
S
0
1600
64.15
D
2829013
D
Common Stock
2018-07-06
4
S
0
5940
65.24
D
2823073
D
Common Stock
2018-07-06
4
S
0
8723
66.16
D
2814350
D
Common Stock
2018-07-06
4
S
0
2637
66.96
D
2811713
D
Common Stock
2018-07-06
4
S
0
600
65.61
D
106128
I
By Family Partnership
Common Stock
2018-07-06
4
S
0
318
66.80
D
105810
I
By Family Partnership
Common Stock
19500
I
By Spouse
Common Stock
60946
I
See footnote
Stock Option (Right to Buy)
3.60
2018-07-05
4
M
0
10320
0.00
D
2019-03-11
Common Stock
10320
319901
D
Stock Option (Right to Buy)
3.60
2018-07-06
4
M
0
10320
0.00
D
2019-03-11
Common Stock
10320
309581
D
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $63.35 to $64.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $64.35 to $65.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $63.50 to $64.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $63.75 to $64.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $64.75 to $65.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $65.75 to $66.725. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $66.80 to $67.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $64.925 to $65.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $66.70 to $67.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.
Fully vested.
/s/ Dorothy Pacini, Attorney-in-fact
2018-07-06